Radboudumc and partners

Innovation requires collaboration

Our mission is to have a significant impact on healthcare. We aim to be a front runner in the development of sustainable, innovative, and affordable healthcare.

collaboration opportunities

contact

news

spin-off companies

licensing opportunities

News

setup e-mail alert

Digital Health partners around Nijmegen join forces

26 January 2022

Health Valley has published a Digital Health Guide to connect Digital Health parties around Nijmegen and beyond.

Aiosyn is awarded the NWO Take Off Phase II grant

23 December 2021

Aiosyn, a Radboudumc spin-off company that develops AI-powered pathology algorithms for clinical diagnostics and life sciences, was awarded early-phase funding of Eur 250.000 by NWO (Dutch Research Council).

ATRO Medical closes a new financing round for the Trammpolin® meniscus prosthesis

17 December 2021

ATRO Medical announces the successful closure of a €1.9 million financing round to complete the AIR2 clinical study.

T-Guard can reset immune system

1 December 2021

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

Setup e-mail alerts

Something went wrong!

Something went wrong while requesting this page. Please try again.

Email address *

Would you like to receive e-mail updates?

Select the frequency of how often you would like to receive an e-mail alert

None Immediate Daily Weekly